Drug Type Polymer |
Synonyms- |
Target |
Action antagonists |
Mechanism αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Preclinical | China | 14 Dec 2018 | |
| Non-Small Cell Lung Cancer | Preclinical | China | 14 Dec 2018 |





